Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2006-09-19
2006-09-19
Lewis, Patrick (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C514S045000, C514S047000, C536S027300, C536S027600, C536S027610, C536S027700
Reexamination Certificate
active
07109180
ABSTRACT:
2-adenosine C-pyrazole compounds having formula (a) and methods for using the compounds as A2A receptor agonists to stimulate mammalian coronary vasodilatation for therapeutic purposes and for purposes of imaging the heart
REFERENCES:
patent: 4956345 (1990-09-01), Miyasaka et al.
patent: 5189027 (1993-02-01), Miyashita et al.
patent: 5270304 (1993-12-01), Kogi et al.
patent: 5459254 (1995-10-01), Yamaguchi et al.
patent: 5593975 (1997-01-01), Cristalli
patent: 5705491 (1998-01-01), Yamada
patent: 5770716 (1998-06-01), Khan et al.
patent: 5939543 (1999-08-01), Morozumi et al.
patent: 6026317 (2000-02-01), Verani
patent: 6214807 (2001-04-01), Zablocki et al.
patent: 965411 (1975-04-01), None
patent: 0 354 638 (1990-02-01), None
patent: S48-26038 (1973-08-01), None
patent: 5-9197 (1993-01-01), None
patent: WO 98/52611 (1998-11-01), None
patent: WO 98/57651 (1998-12-01), None
Marumoto, et al., “Synthesis and Coronary Vadodilating Activity of 2-Substituted Adenosines”,Chem . . . Pharm. Bull. 23(4): 759-774 (1975).
Marumoto, et al., “Synthesis and Enzymatic Activity of Adenosine 3'5'-Cyclic Phosphate Analogs”, Chem. Pharm. Bull. 27(4) 990-1003 (1979).
Persson, et al., “Synthesis and Antiviral Effects of 2-Heteroaryl Substituted Adenosine and 8-Heteroaryl Substituted Guanosine Derivatives”,Bioorganic&Medicinal Chemistry, 3:1377-1382 (1995).
Mager, et al., “Molecular simulation applied to 2-(N'alkylidenehydrazino)- and 2-(N'aralkylidenehydrazino) adenosine A2Agnonists”,Eur J. Med. Chem, 30:15-25 (1995).
Cristalli et al., “2-Alkynl Derivatives of Adenosine 5'-N'ethyluronamide: Selective A2Adenosine Receptor Agonists with Potent Inhibitory Activity on Platelet Aggregation”,J. Med. Chem, 37:1720-1726 (1994).
Matsuda, et al., “Nucleosides and Nucleotides. 103. 2-Alkynyladenoines: A Novel Class of Selective Adenosine A2Receptor Agonists with Potent Antihypertensive Effects”,J. Med. Chem. 35:241-252 (1992).
Elzein Elfatih O.
Palle Venkata P.
Zablocki Jeff A.
CV Therapeutics Inc.
Lewis Patrick
LandOfFree
C-pyrazole A 2A receptor agonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with C-pyrazole A 2A receptor agonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and C-pyrazole A 2A receptor agonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3603794